ArticleClinical epigenetics2023

Evaluation of commercial kits for isolation and bisulfite conversion of circulating cell-free tumor DNA from blood.

Stine H Kresse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.